Colonial Trust Advisors’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Other funds holding TAK
Colonial Trust Advisors's TAK Position: Q3 2026 in Review
Colonial Trust Advisors held its Takeda Pharmaceutical (TAK) position steady in Q3 2026 at 352 shares worth $6.4K. The position accounts for ﹤0.01% of the portfolio, ranked #633.
Colonial Trust Advisors first reported a position in TAK in Q4 2022 and has held it in 16 quarters since. The position peaked at $6.52K in Q1 2026. 400 funds tracked by Wall St. Rank hold TAK as of Q3 2026.
- Colonial Trust Advisors held 352 shares of Takeda Pharmaceutical worth $6.4K as of Q3 2026.
- Colonial Trust Advisors left its Takeda Pharmaceutical share count unchanged in Q3 2026.
- Takeda Pharmaceutical made up ﹤0.01% of Colonial Trust Advisors's portfolio in Q3 2026, its #633 holding.
- Colonial Trust Advisors first reported a position in Takeda Pharmaceutical in Q4 2022 and has held it in 16 quarters since.
- Colonial Trust Advisors's Takeda Pharmaceutical position peaked at $6.52K in Q1 2026.
- 400 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.
Based on Colonial Trust Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.